Arteaga CL - Search Results

1

Human breast cancer cells harboring a gatekeeper T798M mutation in HER2 overexpress EGFR ligands and are sensitive to dual inhibition of EGFR and HER2.

Rexer BN, Ghosh R, Narasanna A, Estrada MV, Chakrabarty A, Song Y, Engelman JA, Arteaga CL. Rexer BN, et al. Among authors: arteaga cl. Clin Cancer Res. 2013 Oct 1;19(19):5390-401. doi: 10.1158/1078-0432.CCR-13-1038. Epub 2013 Aug 15. Clin Cancer Res. 2013. PMID: 23948973 Free PMC article.

2

Interference of the IGF system as a strategy to inhibit breast cancer growth.

Arteaga CL. Arteaga CL. Breast Cancer Res Treat. 1992;22(1):101-6. doi: 10.1007/BF01833338. Breast Cancer Res Treat. 1992. PMID: 1421419 Review.

3

Growth stimulation of human breast cancer cells with anti-transforming growth factor beta antibodies: evidence for negative autocrine regulation by transforming growth factor beta.

Arteaga CL, Coffey RJ Jr, Dugger TC, McCutchen CM, Moses HL, Lyons RM. Arteaga CL, et al. Cell Growth Differ. 1990 Aug;1(8):367-74. Cell Growth Differ. 1990. PMID: 2177634

4

Ligand-like effects induced by anti-c-erbB-2 antibodies do not correlate with and are not required for growth inhibition of human carcinoma cells.

Shawver LK, Mann E, Elliger SS, Dugger TC, Arteaga CL. Shawver LK, et al. Among authors: arteaga cl. Cancer Res. 1994 Mar 1;54(5):1367-73. Cancer Res. 1994. PMID: 7907001

5

p185c-erbB-2 signal enhances cisplatin-induced cytotoxicity in human breast carcinoma cells: association between an oncogenic receptor tyrosine kinase and drug-induced DNA repair.

Arteaga CL, Winnier AR, Poirier MC, Lopez-Larraza DM, Shawver LK, Hurd SD, Stewart SJ. Arteaga CL, et al. Cancer Res. 1994 Jul 15;54(14):3758-65. Cancer Res. 1994. PMID: 7913407

6

Epidermal growth factor receptors in human breast carcinoma cells: a potential selective target for transforming growth factor alpha-Pseudomonas exotoxin 40 fusion protein.

Arteaga CL, Hurd SD, Dugger TC, Winnier AR, Robertson JB. Arteaga CL, et al. Cancer Res. 1994 Sep 1;54(17):4703-9. Cancer Res. 1994. PMID: 8062268

7

Transforming growth factor beta 1 can induce estrogen-independent tumorigenicity of human breast cancer cells in athymic mice.

Arteaga CL, Carty-Dugger T, Moses HL, Hurd SD, Pietenpol JA. Arteaga CL, et al. Cell Growth Differ. 1993 Mar;4(3):193-201. Cell Growth Differ. 1993. PMID: 8466857

8

Tissue-targeted antisense c-fos retroviral vector inhibits established breast cancer xenografts in nude mice.

Arteaga CL, Holt JT. Arteaga CL, et al. Cancer Res. 1996 Mar 1;56(5):1098-1103. Cancer Res. 1996. PMID: 8640767

9

Predominant cytosolic localization of type II transforming growth factor beta receptors in human breast carcinoma cells.

Koli KM, Arteaga CL. Koli KM, et al. Among authors: arteaga cl. Cancer Res. 1997 Mar 1;57(5):970-7. Cancer Res. 1997. PMID: 9041203

10

Abrogation of cisplatin-induced programmed cell death in human breast cancer cells by epidermal growth factor antisense RNA.

Dixit M, Yang JL, Poirier MC, Price JO, Andrews PA, Arteaga CL. Dixit M, et al. Among authors: arteaga cl. J Natl Cancer Inst. 1997 Mar 5;89(5):365-73. doi: 10.1093/jnci/89.5.365. J Natl Cancer Inst. 1997. PMID: 9060958

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

425 results

Search Page

Filters